Daiken Medical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 4, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	13,474	14,077	15,944	13,818	14,652	17,496
Market Cap Growth	-6.20%	-11.71%	15.38%	-5.69%	-16.26%	-7.31%
Enterprise Value	12,941	13,444	15,955	14,329	15,410	18,475
Last Close Price	469.00	480.54	520.30	434.32	441.70	508.91
PE Ratio	13.73	12.83	16.14	19.41	17.63	25.92
PS Ratio	1.33	1.42	1.64	1.51	1.72	2.23
PB Ratio	1.75	1.87	2.27	2.10	2.27	2.83
P/TBV Ratio	1.75	1.88	2.28	2.10	2.28	2.84
P/FCF Ratio	-	14.76	11.45	17.47	15.74	58.32
P/OCF Ratio	-	12.57	10.25	13.97	12.93	28.73
EV/Sales Ratio	1.27	1.35	1.64	1.57	1.80	2.35
EV/EBITDA Ratio	-	7.71	9.63	10.84	10.52	15.70
EV/EBIT Ratio	9.87	8.89	11.06	13.58	13.39	20.06
EV/FCF Ratio	-	14.09	11.45	18.12	16.55	61.58
Debt / Equity Ratio	0.24	0.27	0.31	0.42	0.46	0.48
Debt / EBITDA Ratio	-	1.18	1.29	2.08	2.00	2.51
Debt / FCF Ratio	-	2.15	1.54	3.48	3.15	9.84
Net Debt / Equity Ratio	-0.07	-0.13	-0.08	0.04	0.06	0.13
Net Debt / EBITDA Ratio	-	-0.54	-0.36	0.18	0.28	0.67
Net Debt / FCF Ratio	-	-0.99	-0.43	0.30	0.45	2.61
Asset Turnover	0.90	0.90	0.89	0.83	0.79	0.72
Inventory Turnover	4.56	4.08	3.91	3.67	3.28	3.47
Quick Ratio	1.82	1.93	1.56	1.50	1.57	1.42
Current Ratio	2.40	2.47	2.02	1.97	2.09	1.87
Return on Equity (ROE)	13.01%	15.09%	14.51%	10.92%	13.16%	11.01%
Return on Assets (ROA)	7.29%	8.52%	8.19%	6.01%	6.64%	5.29%
Return on Invested Capital (ROIC)	13.94%	16.94%	14.99%	10.71%	12.02%	9.69%
Return on Capital Employed (ROCE)	15.90%	18.10%	18.80%	13.80%	14.80%	12.40%
Earnings Yield	7.28%	7.79%	6.20%	5.15%	5.67%	3.86%
FCF Yield	-	6.78%	8.74%	5.72%	6.35%	1.71%
Payout Ratio	-	55.79%	58.00%	79.35%	69.07%	85.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.